Minor
18F-Florastamin PET/CT Imaging · Suspected Recurrence of Prostate Cancer
Trial completed
Also in this update: Primary completion date changed from estimate of Jan 1, 2026 to Jun 11, 2026
HTA Co., Ltd.Phase 3 NCT06754085 Registry history of NCT06754085 on ClinicalTrials.gov (opens the registry)